Skip to main content
PLOS One logoLink to PLOS One
. 2025 Jun 18;20(6):e0325780. doi: 10.1371/journal.pone.0325780

Mental health and health-related quality of life among adults with osteoarthritis: A national population-based study

Monira Alwhaibi 1,*,#, Tariq M Alhawassi 1,#
Editor: Zulkarnain Jaafar2
PMCID: PMC12176145  PMID: 40531897

Abstract

Background

Adults with osteoarthritis are vulnerable to mental health disorders, which may have a significant impact on their Health-Related Quality of Life (HRQoL). Thus, the purpose of this study was to look at the relationship between anxiety and depression and HRQoL in adults with osteoarthritis.

Methods

Adult patients diagnosed with osteoarthritis who were 18 years of age or older were identified using data from the Medical Expenditure Panel Survey for the years 2018–2021. HRQoL was computed using the veteran’s RAND 12-item health survey which has two domains the Physical and Mental Component Summary (PCS & MCS) ratings. The link between anxiety and depression and HRQoL in individuals with osteoarthritis was examined using multivariable linear regression after the adjustment for a variety of covariates.

Results

Of the 3,658 individuals with osteoarthritis that were identified, 12.0% experienced depression, 12.5% had anxiety, and 9.9% had both illnesses. The PCS and MCS mean scores of the HRQoL were lowest for persons with comorbid depression and anxiety compared to adults with osteoarthritis only. Moreover, from the adjusted regression analysis, adults with osteoarthritis who had depression (MCS: adjusted β = −5.408, p < 0.001), anxiety (MCS: adjusted β = −3.485, p < 0.001), or both depression and anxiety (MCS: adjusted β = −10.348, p-value<0.0001) had significantly lower HRQoL MCS scores compared to those with osteoarthritis only. Those who were physically active and employed had notably better scores on the PCS and MCS than those who were not.

Conclusions

This nationally representative sample has shed light on the relationships between anxiety, depression, and a low HRQoL in adults with osteoarthritis. The study also revealed the impact of socioeconomic factors such as education level and income on HRQoL, and the benefits of employment and regular exercise. Importantly, the findings underscore the need for lifestyle modifications to reduce anxiety and depression in individuals with osteoarthritis. They also highlight the practical implications for healthcare planning and resource allocation, providing valuable insights for policymakers and healthcare professionals.

1. Introduction

Osteoarthritis (OA) is one of the most prevalent disabling illnesses globally and has been shown to have serious adverse effects on health [1]. It was estimated that OA affected around six hundred million individuals worldwide in 2020, representing 7.6% of the world’s population [2]. Moreover, OA cases are expected to rise by nearly 50% for the hand, 75% for the knee and the hip, and up to 95% increase in OA prevalence for other types by 2050 as compared to 2020 [2]. Nowadays, OA is the 14th leading cause of age-standardized years lived with disability (YLDs) globally and has a substantial burden on individuals characterized by pain, limitations of activity, and diminished quality of life [2]. In addition to the direct health-related burden, OA has a significant financial burden and detrimental effects on a person’s psychological health and well-being, work participation, sleep, mobility, and diminished health-related quality of life (HRQoL) [1,3–10]. Therefore, individuals with OA have three times more potential than individuals in the general population to experience anxiety and depression, which could be attributed to pain severity, poor function, number of OA sites, immunological inflammation, and structural alterations in the brain [11–13].

Anxiety and depression can increase the risk of adverse clinical outcomes, such as OA illness burden and morbidity, and also result in increased healthcare costs and health service utilization, with higher healthcare provider visits, emergency room visits, and hospitalizations [12,14–16]. Besides, depression was associated with lower HRQoL for individuals with OA [17,18]. HRQoL is a crucial outcome measure for evaluating the overall effects of long-term illnesses like OA, including a person’s social, emotional, and physical well-being [19].

With the aforementioned risk of OA on patients’ psychological well-being, maintaining a high quality of life in terms of health despite the difficulties posed by OA is a primary objective for adult OA sufferers and their healthcare providers. Therefore, understanding the causes underlying a lower HRQoL becomes essential, especially when considering mental health. Although prior studies have explored the impact of mental health on health-related quality of life (HRQoL) in individuals with osteoarthritis (OA), many face methodological and contextual limitations that restrict their applicability to broader populations or policymaking. [6,12,15,17–21]. For example, Chang et al. (2023), Lee et al. (2020), and Kim et al. (2019) used data from the Korean National Health and Nutrition Examination Survey (KNHANES), but the diagnoses of OA and mental health conditions were self-reported without clinical validation, raising concerns about measurement accuracy. Tsuji et al. (2019) employed Internet-based survey methods via the National Health and Wellness Survey (NHWS), introducing potential selection bias, especially underrepresentation of older adults. Barbosa et al. (2022) conducted their analysis on a small sample (n = 107), limiting statistical power and generalizability. Tavares et al. (2022), reported heavy reliance on subjective measures (e.g., visual analog scales) and gender imbalance further limit the robustness of conclusions.

These cumulative limitations from small or biased samples to omitted confounders underscore the need for comprehensive, population-based analyses using validated instruments and broader covariate adjustment. Our study addresses these gaps by leveraging nationally representative data from the Medical Expenditure Panel Survey (MEPS, 2018–2021), which includes clinically coded OA diagnoses (ICD-10-CM), validated HRQoL measures (VR-12), and extensive information on social determinants, comorbidities, and health behaviors. This approach allows us to offer more generalizable and clinically relevant insights into how depression and anxiety affect HRQoL in adults with OA. Therefore, this led us to conduct this research, which aimed at evaluating the association between depression, anxiety, and the HRQoL among adults with OA using a sample from a representative United States (US) database and adding more insightful knowledge to the currently available research in this significant field.

2. Methods

2.1. Study design and data

This study employed a retrospective longitudinal design using data from the 2020–2021 cycle of the Medical Expenditure Panel Survey (MEPS), a nationally representative survey of the U.S. noninstitutionalized civilian population conducted by the Agency for Healthcare Research and Quality (AHRQ). MEPS utilizes an overlapping panel structure in which data are collected from households over two calendar years using a stratified, multistage probability sampling design. Data collection is conducted through multiple rounds of computer-assisted personal interviews. No ethical review or approval was needed as we have utilized a publicly accessible, the Medical Expenditure Panel Survey (MEPS) database. Medical Expenditure Panel Survey (MEPS) database is publicly accessible secondary data, therefore, patient consent was waived for this research.MEPS provides extensive information on a range of variables, including demographic characteristics, chronic health conditions, healthcare utilization and expenditures, access to and satisfaction with care, health insurance coverage, income, and employment status. Medical conditions reported by respondents are based on health issues experienced during the data collection period. These self-reported conditions are recorded verbatim during the interviews and subsequently coded by professional coders into standardized International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes.

2.2. Study population

According to the study’s inclusion criteria, an adult must be between 18 and 64 years old, have a diagnosis of OA, alive within the study period, and have no missing data on HRQoL. The International Classification of Diseases, tenth Revision, Clinical Modification (ICD-10-CM) clinical diagnosis codes were used to identify OA from MEPS data (M16: osteoarthritis of the hip, M17: osteoarthritis of the knee, M19: other and unspecified osteoarthritis) [22].

2.3. Measures

2.3.1. Outcome: Health-related quality of life (HRQoL).

To evaluate the HRQoL, adults who participated in the MEPS filled out a questionnaire using a reliable and valid instrument, the Veterans RAND 12 Item Health Survey (VR-12©) [23–25]. VR-12 is a 12-item patient-reported outcome measure that evaluates eight domains of health: general health, physical functioning, role physical, bodily pain, vitality, role emotional, mental health, and social functioning [23]. The VR-12 has two parts: 1/ Physical Component Summary (PCS), which included responses from the general health, physical functioning, role physical, and bodily pain domains, and 2/ Mental Component Summary (MCS), which included responses from role emotional, vitality, mental health, and social functioning domains [26]. Scores range from 0 to 100, with higher PCS and MCS scores as better physical and mental HRQoL indicators.

2.4.2. Independent variables.

The primary independent variable of interest in this study was the osteoarthritis (OA) group classification, defined as mutually exclusive categories: OA only, OA with anxiety, OA with depression, and OA with both anxiety and depression. Additional covariates were selected based on well-established evidence of their association with health-related quality of life (HRQoL) in adults with OA. These include sociodemographic variables (age, gender, education, income, employment, marital status, and region). These are key social determinants of health known to influence both physical and mental HRQoL [27–33]. A health behavior (physical activity) has been selected as regular exercise is strongly associated with improved physical function and mental well-being in OA populations. Perceived health status has been included as self-rated health is a robust predictor of HRQoL. Chronic comorbidities (e.g., hypertension, diabetes, asthma, COPD, GERD), are frequently observed in individuals with OA and contribute significantly to the overall disease burden and quality of life. Health insurance coverage, included as a proxy for access to healthcare services, which can directly affect HRQoL outcomes.

2.5. Statistical analyses

Descriptive statistics were employed to show the study sample’s baseline characteristics, including mean, standard deviation, frequencies, and percentages. The differences in individual characteristics between the OA groups were evaluated using chi-square tests. The mean variances in HRQoL by OA groups were determined using ANOVA followed by Tukey’s post hoc test for multiple comparisons to identify which specific groups differed. To assess the link between OA groups and HRQoL, we used multivariable linear regression and adjusted for all independent covariates. Variables were included in the model based on their theoretical relevance, clinical importance, and prior literature supporting their association with health-related quality of life (HRQoL) in OA patients [27–33]. Additionally, a bivariate analysis was performed and only variables with a likelihood ratio p-value of <0.05 were considered for the multivariable regression model. All the underlying assumptions of the linear regression model have been evaluated to ensure that they are satisfied by the regression model and are met by the variables. Those assumptions include correct model specification, normality, homoscedasticity, no autocorrelation, and no multicollinearity. After checking the underlying assumptions, we performed the linear regression model. All estimations in the statistical analysis considered the complicated survey design of the MEPS by integrating variance adjustment weights (strata and primary sample unit) from the MEPS with person-level weights. The Statistical Analysis System, SAS 9.4 (SAS Institute Inc., Cary, NC, USA), was used to analyze the data.

3. Results

3.1. Characteristics of the study sample

Table 1 lists the characteristics of the study sample, 3,658 adults with OA; the majority of the study sample was women (62.3%), aged 50–64 (72.0%), White (73.3%), and had higher than high school (87.8%). About 12.0% of adults with OA also experienced depression, 12.5% had anxiety, and 9.9% had both illnesses.

Table 1. Socio-economic and health-related characteristic of study participants across osteoarthritis groups.

Total Sample OA Only OA & Depression OA & Anxiety OA & Depression & Anxiety P-value*
N Wt.% N Wt.% N Wt.% N Wt.% N Wt.%
All 3,658 100.0 2361 65.6 473 12.0 429 12.5 395 9.9
Age in years
 22-39 327 9.7 187 54.4 31 10.8 52 16.8 57 18.0 <0.0001
 40-49 648 18.2 384 62.4 87 12.7 90 13.4 87 11.5
 50-64 2683 72.0 1790 67.9 355 12.0 287 11.7 251 8.4
Gender
 Women 2405 62.3 1437 59.8 336 13.6 319 14.7 313 12.0 <0.0001
 Men 1253 37.7 924 75.2 137 9.3 110 9.0 82 6.5
Race/ethnicity
 White 2304 73.3 1412 63.5 318 12.4 305 13.8 269 10.2 0.011
 African American 658 12.5 482 73.6 66 9.5 62 8.5 48 8.4
 Latino 488 8.8 336 72.1 58 11.3 42 8.1 52 8.5
 Others 208 5.4 131 64.9 31 13.0 20 11.1 26 11.0
Marital status
 Married 1749 54.8 1232 71.0 190 10.3 199 12.2 128 6.5 <0.0001
 Widow/Sep/Div 1250 30.2 712 57.6 200 14.1 166 13.9 172 14.4
 Never married 659 15.0 417 62.1 83 13.7 64 11.0 95 13.2
Education level
 <High School 197 3.4 133 70.8 24 12.2 22 9.8 18 7.2 0.015
 High School 395 8.0 240 61.7 54 13.2 38 8.7 63 16.5
 > High School 3033 87.8 1965 65.7 392 11.9 365 13.0 311 9.4
Region
 Northeast 589 16.9 385 68.3 70 9.4 57 10.1 77 12.2 0.356
 Mid-west 939 26.3 572 63.4 145 13.9 113 12.2 109 10.4
 South 1444 38.8 946 64.9 169 12.5 175 13.1 154 9.5
 West 686 18.0 458 67.7 89 10.5 84 14.1 55 7.7
Employment
 Employed 1942 60.8 1399 72.0 192 9.3 198 11.3 153 7.5 <0.0001
 Not employed 1716 39.2 962 55.7 281 16.2 231 14.4 242 13.7
Poverty status
 Poor 814 15.8 441 50.7 127 15.8 114 15.5 132 18.0 <0.0001
 Near Poor 723 16.0 423 57.7 112 16.8 93 13.3 95 12.2
 Middle Income 911 24.8 606 66.4 123 12.7 101 12.4 81 8.6
 High Income 1210 43.5 891 73.5 111 8.4 121 11.2 87 6.8
Health Insurance
 Private 2098 67.0 1507 71.9 227 9.8 210 11.2 154 7.1 <0.0001
 Public 1415 29.4 755 51.3 227 16.6 207 15.7 226 16.4
 Uninsured 145 3.6 99 65.5 19 14.0 12 11.2 15 9.3
Rx Insurance
 Rx insurance 1850 59.4 1347 72.8 185 9.3 187 11.1 131 6.8 <0.0001
 No Rx insurance 1808 40.6 1014 55.1 288 15.9 242 14.5 264 14.4
General health
 Excellent/very good 1002 31.3 770 77.2 100 8.5 96 10.9 36 3.4 <0.0001
 Good 1302 36.8 876 66.8 154 11.7 146 11.9 126 9.6
 Fair/poor 1354 31.9 715 52.8 219 15.8 187 14.8 233 16.6
Physical activity
 3/week 1496 43.1 1054 71.2 169 9.8 156 12.0 117 7.0 <0.0001
 No exercise 2158 56.8 1305 61.4 302 13.6 273 12.9 278 12.1
Heart Disease
 Yes 422 10.5 235 58.6 63 14.7 62 13.8 62 12.8 0.111
 No 3236 89.5 2126 66.4 410 11.7 367 12.4 333 9.5
Hypertension
 Yes 1820 45.9 1107 62.6 272 14.2 236 12.9 205 10.2 0.017
 No 1838 54.1 1254 68.2 201 10.1 193 12.2 190 9.6
Diabetes
 Yes 848 21.3 471 56.0 149 17.5 99 12.7 129 13.7 <0.0001
 No 2810 78.7 1890 68.2 324 10.5 330 12.5 266 8.9
Hyperlipidemia
 Yes 1359 35.6 788 60.0 208 14.3 185 14.1 178 11.5 0.004
 No 2299 64.4 1573 68.7 265 10.7 244 11.6 217 9.0
Asthma
 Yes 706 17.5 363 52.5 105 14.7 103 15.3 135 17.6 <0.0001
 No 2952 82.5 1998 68.4 368 11.4 326 11.9 260 8.3
COPD
 Yes 432 10.9 214 49.7 61 15.1 67 16.1 90 19.1 <0.0001
 No 3226 89.1 2147 67.5 412 11.6 362 12.1 305 8.8
GERD
 Yes 719 18.4 382 53.2 111 15.6 105 15.0 121 16.2 <0.0001
 No 2939 81.6 1979 68.4 362 11.2 324 12.0 274 8.5
*

Significant differences in osteoarthritis (OA) groups were represented by chi-square tests of likelihood ratio p-value.

COPD: Chronic obstructive pulmonary disease; GERD: Gastroesophageal reflux disease; Wt: weighted; Rx: Medication; Wid./Div./Sep.: widowed, divorced, and separated

Women with OA showed significantly higher rates of depression (13.6% vs. 9.3%), anxiety (14.7% vs. 9.0%), and comorbid anxiety and depression (12.0% vs. 6.5%, p-value = < 0.0001) when compared to men. Furthermore, unemployed OA patients had significantly higher rates of depression (16.2% vs. 9.3%) and comorbid anxiety and depression (13.7% vs. 7.5%, p-value <0.0001) than employed OA patients. OAs adults with diabetes, asthma, COPD, and GERD had significantly higher rates of comorbid depression and anxiety than those without these comorbidities (p-value <0.0001).

3.2. Health-related quality of life and osteoarthritis groups

A significant difference in the PCS and MCS scores was found between OA groups using ANOVA (Table 2). For example, OA adults with both depression and anxiety had a significantly lower mean PCS score (Mean = 36.84, SE = 0.78) and MCS score (Mean = 37.47, SE = 0.74) compared to other groups (Mean MSC score was 51.20 for OA only, 42.73 for OA and depression, and 45.71 for OA and anxiety). ANOVA test, which had shown a significant difference in all groups as P < 0.0001, was followed by Tukey’s Post Hoc test for multiple comparisons, which found that regarding the PCS score, adults with OA only have a significantly higher mean PCS score as compared to the other groups (OA and anxiety, OA and depression, and OA and anxiety and depression). Also, adults with OA and anxiety/depression have a significantly lower mean PCS score as compared to all groups. Regarding the MCS score, adults with OA only have a significantly higher mean MCS score as compared to the other groups. Also, adults with OA and anxiety/depression have a significantly lower mean MCS score as compared to all other groups. In summary, patients with only OA without any mental health disorder have the highest level of PCS and MCS scores (quality of life).

Table 2. Health-related Quality of Life Weighted Means Scores by Osteoarthritis (OA) Groups.

Total Sample OA Only OA & Depression OA & Anxiety OA & Depression & Anxiety
Mean SD Mean SE Mean SE Mean SE Mean SE p-value
HRQoL
 PCS 39.91 12.43 43.12 0.32 37.39 0.79 40.91 0.78 36.84 0.78 <0.0001
 MCS 47.21 11.00 51.20 0.22 42.73 0.61 45.71 0.61 37.47 0.74 <0.0001

Mean differences between osteoarthritis groups were analyzed using an ANOVA test.

HRQoL: Health-related Quality of Life; SE: Standard Error; SD: Standard Deviation; Sig: Significance.

3.3. Health-related quality of life among osteoarthritis groups from linear regression analysis

Table 3 shows the adjusted relationship between OA groups and HRQoL. After controlling for all independent variables, OA adults with depression (MCS: β = −6.124), anxiety (MCS: β = −3.424), and both depression and anxiety (MCS: β = −10.317) had a significantly lower HRQoL mental health domain compared to those with OA only (p-value<0.0001).

Table 3. Adjusted multivariable linear regressions on HRQoL among adults with osteoarthritis.

Health-Related Quality of Life
Physical Health Summary (PCS) Mental Health Summary (MCS)
Regression
Coefficients
SE Sig. Regression
Coefficients
SE Sig.
Osteoarthritis (OA) Group
 OA & depression −1.042 0.716 −6.124 0.810 ***
 OA & anxiety 1.316 0.736 −3.424 0.617 ***
 OA & depression & anxiety −0.759 0.850 −10.317 0.855 ***
 OA only (Ref.)
Age in years
 22-39 2.398 1.029 * −3.119 0.847 ***
 40-49 0.575 0.776 −2.002 0.682 **
 50-64 (Ref.)
Gender
 Men 0.198 0.531 −0.182 0.449
 women (Ref.)
Race/ethnicity
 African American 1.133 0.728 0.832 0.631
 Latino 1.245 0.839 −1.319 0.807
 Others −0.496 1.091 −1.404 1.108
 White (Ref.)
Marital status
 Married −0.519 0.620 0.000 0.561
 Widow/Separated/Divorce 0.471 0.693 0.591 0.642
 Never married (Ref.)
Education level
 > High School −2.203 1.385 1.469 1.433
 High School −2.906 1.461 * 2.815 1.527
 <High School (Ref.)
Region
 Northeast 1.448 0.608 * 0.029 0.665
 Mid-west 3.023 0.749 *** −0.321 0.933
 South 1.058 0.604 −0.053 0.682
 West (Ref.)
Employment
 Employed 4.588 0.673 *** 2.858 0.491 ***
 Not employed (Ref.)
Poverty status
 Poor −2.115 0.857 * −1.205 0.853
 Near Poor −0.684 0.842 −1.058 0.800
 Middle Income −0.981 0.647 0.400 0.577
 High Income (Ref.)
Health Insurance
 Private 3.034 1.590 0.822 1.253
 Public −1.696 1.702 0.711 1.233
 Uninsured (Ref.)
Rx Insurance
 Rx insurance 0.863 0.833 −0.957 0.766
 No Rx insurance (Ref.)
General health
 Excellent/very good 11.075 0.710 *** 6.215 0.626 ***
 Good 6.175 0.613 *** 4.004 0.616 ***
 Fair/poor (Ref.)
Physical activity
 3/week 3.382 0.469 *** 0.918 0.439 *
 No exercise (Ref.)
Heart Disease
 Yes −0.486 0.776 −0.729 0.784
Hypertension
 Yes −1.840 0.494 *** −0.089 0.519
Diabetes
 Yes −0.928 0.549 −0.079 0.572
Asthma
 Yes −1.338 0.705 −1.175 0.703
COPD
 Yes −0.853 0.791 −0.443 1.066
GERD
 Yes −0.517 0.645 −1.162 0.641

Asterisks denote statistical significance from multivariable linear regression on health-related quality of life among adults with osteoarthritis,

***

P < 0.001;

**

0.001 ≤ P < 0.01;

*

0.01 ≤ P < .05

>: Greater than; < : Less than

COPD: Chronic obstructive pulmonary disease; GERD: Gastroesophageal reflux disease; Rx: Medication; Ref: reference group; SE: Standard Error; Sig: Significance.

OA patients, who were employed, lived in Northeast and Mid-west regions, perceived their physical health to be excellent, and exercised regularly tended to have a better quality of life. For example, OA adults who were employed have a significantly higher HRQoL in both physical health domain (PCS: β = 4.588, p-value<0.0001) and mental health domain (MCS: β = 2.858, p-value<0.0001) compared to those who were not employed.

Several factors were found to negatively impact health-related quality of life (HRQoL), including younger age, education levels, lower income, and hypertension. For instance, adults with lower income, high school education, and hypertension had significantly lower physical health domain compared to those with high income, less than high school education, and those with hypertension (hypertension PCS: β = −1.840, p-value <0.0001). Additionally, younger adults (aged 22–39) reported a significantly lower mental health scores (MCS: β = −3.119, p-value <0.0001) compared to those aged 50–64.

4. Discussion

The findings of this study provide robust evidence that comorbid depression and anxiety are significantly associated with reduced health-related quality of life (HRQoL) among adults with osteoarthritis (OA). By leveraging a nationally representative sample of U.S. adults, our study addressed important gaps in the existing literature, offering greater insight into how these mental health conditions affect both physical and mental HRQoL domains. Interpreting our findings in the context of international research further strengthens their relevance. Consistent patterns have been observed in studies conducted in Korea, Japan, and Brazil, where comorbid anxiety and depression were also shown to adversely impact HRQoL in individuals with OA. For example, data from the Korea National Health and Nutrition Examination Survey identified psychiatric comorbidities as strong predictors of diminished HRQoL among OA populations. Similarly, Tsuji et al. in Japan reported that depressive symptoms were significantly associated with poorer self-rated health and functional outcomes in OA patients. The alignment of our findings with these studies reinforces the global burden of mental comorbidities in OA and supports the external validity of our results.

In our study, we compared four groups of adults with OA in terms of their quality of life: 1) those with OA only, 2) those with OA and depression, 3) those with OA and anxiety, and 4) those with OA and both depression and anxiety. By comparing these groups, we observed that those with anxiety and depression had worse HRQoL than adults with any of these comorbidities only, or without any of them. Adults with OA and both depression and anxiety have a lower PCS score and MCS score compared to those with OA only (PCS score of 36.84 vs. 43.12, MCS score of 37.47 vs. 51.20), presence of anxiety and depression led to a nearly 6-point reduction in PCS score and a 14-point reduction in MCS score among adults with OA. In our adjusted analysis, the β-coefficient for those with both depression and anxiety (MCS: β = −10.317) indicates that having anxiety and depression comorbidity, as opposed to no mental comorbidity in adults with OA is associated with a 10-unit reduction in HRQoL score in the MCS domain. These findings indicate the incremental effect of having anxiety and depression on health status and reflect a greater disease burden of these mental illnesses. Our analysis’s findings concur with those of other previously published research. For example, a study using data from the Korea National Health and Nutrition Examination Survey revealed lower HRQoL in OA adults with psychiatric disease [17]. As nearly one in ten adults with OA in our study have depression or anxiety, these findings suggest the need for OA point-of-care anxiety and depression screening [34], since they are consistently underdiagnosed and neglected. Many general practitioners and primary care providers often overlook these comorbidities because they either only address the physical aspects of OA or neglect to evaluate their patients’ psychological well-being entirely [35]. Understanding these comorbidities is crucial because they can alter OA management and progression. The National Institute for Health and Care Excellence (NICE) has provided guidelines for practitioners to guide them in the holistic evaluation of patients with OA [36]. Therefore, policies and initiatives must promote and support coordinated care that covers OA and mental health management to improve their quality of life, reduce the disease burden, and fill the mental health care gap [37].

Additionally, the results of this study demonstrated that other risk factors including income, education levels, and coexisting hypertension, have an unneglectable impact on HRQoL among adults with OA. In fact, in our descriptive analysis we found that those with high school education level, low income, and those with chronic illnesses have a higher prevalence of depression and anxiety. Previous studies that involved adults in general and adults with OA reported that these are important determinants of HRQoL [6,18,27–33]. The negative association between having high school education and physical health (PCS domain of HRQoL), compared to less than a high school education, may be explained by the higher prevalence of depression and anxiety comorbidity from bivariate analysis in this group, as mental health conditions can exacerbate physical health issues through poor health behaviors. A recently published data from the Epidemiology of Chronic Diseases cohort study, a 10-year follow-up for 983 hip and knee OA patients reported that multimorbidity was associated with a higher risk of poor physical function and HRQoL trajectories [38]. Besides, in earlier studies, chronic illnesses are linked to mental health and are associated with a reduced HRQoL in their sufferers because of their chronic nature and management [39–41]. Given that enhancing HRQoL is seen as a noteworthy outcome and a predictor of disease management, it emphasizes the need for comprehensive care that addresses OA management and physical and mental comorbidities. Recognizing income, education, and chronic illnesses as essential factors in adults with OA can guide healthcare providers in identifying of OA individuals who may be at higher risk of experiencing poor HRQoL and tailoring interventions accordingly. For example, targeting those with low education and income with additional preventative strategies can help in mitigate the negative impact of such risk factors and prevent or minimize impairment in the quality of life of individuals with OA.

Furthermore, this study found that OA adults who were employed, lived in Northeast and Mid-west regions, perceived their physical health to be excellent, exercise regularly had higher HRQoL. Employment was particularly associated with improved physical and mental well-being, likely due to financial stability, social engagement, and a sense of purpose. Additionally, individuals with higher incomes generally experienced better health outcomes, emphasizing the role of economic security in maintaining a good quality of life. Perceived health played a crucial role in overall well-being, as individuals who rated their physical health as excellent experienced significantly better quality of life. This suggests that self-assessment of health status is a strong predictor of both physical and mental well-being. Additionally, regional differences in HRQoL were observed, with those residing in the Northeast and Midwest regions reporting better health outcomes. This could be attributed to variations in healthcare access, socioeconomic conditions, environmental factors, or community support systems available in these areas.

Physical activity also emerged as a key contributor to improved HRQoL. Prior research investigated the effects of physical activity on OA patients’ physical function and HRQoL using a statewide population-based cohort reported that regular physical activity was related to enhanced physical function and HRQoL among individuals with hip and/or Knee OA [13,42]. The results of this study further highlighted the necessity of managing OA through a multidisciplinary approach that includes lifestyle, psychological, and pharmacological interventions customized to each patient’s needs to lessen the negative effects of coexisting mental conditions and, therefore, improve the overall quality of life.

4.1. Study strengths and limitations

This study used a large sample size and a nationally representative sample of US adults with OA, which allowed us to obtain a clinically insightful estimate of the relationship between depression and anxiety and HRQoL in adults with OA. However, this study has some limitations. First, the cross-sectional design of our study limits its ability to determine the causal relationship between depression, anxiety, and HRQoL. Second, specific critical confounders were not available on MEPS data and have not been adjusted for in the analysis, including osteoarthritis-related variables (i.e., treatment, the severity of their illness, disease subtypes, OA-related pain, pain-severity, and pain location (hip vs. knee joint)) which can interfere with a person’s ability to function normally and have a negative relationship with HRQoL [17,38,43,44]. These essential confounders were overlooked, which all have a significant role in influencing HRQoL in adults with OA and are crucial to comprehending the intricate relationship between mental health and OA patients’ HRQoL. Third, missing these critical OA-related variables in the analysis may have introduced a potential omitted variable bias and weakened the study’s findings and conclusion; thus, the results of this study may have overestimated the direct impact of anxiety and depression on HRQoL in persons with osteoarthritis, therefore, adding these crucial factors should be the top priority for future research. However, in this study’s analysis compared to previously published research, an adjustment for several essential confounders that can potentially affect the HRQoL, such as social determinants, chronic illnesses, physical activity, health insurance coverage, and perceived health, were included to produce greater confidence in detecting the actual effect of mental health on HRQoL in adults with OA [27–33]. Finally, the fact that data on HRQoL and OA symptoms are mostly self-reported introduces a potential source for biases such as underreporting or misreporting bias.

4.2. Clinical practice, policy and public health, and research implications

The clinical practice implication of the results of our research should reassure us that physicians, rheumatologists, and mental health professionals should incorporate routine screening for anxiety and depression in adults with OA, especially when patients or their families report symptoms [45]. This can help minimize suffering, improve symptom management, and enhance HRQoL. Clinicians should adhere to the NICE guidelines on identifying and treating depression, utilizing a combination of pharmacotherapy, cognitive-behavioral therapy (CBT), physical therapies, and structured activities to optimize treatment outcomes [46]. Some research suggested that the use of CBT, education programs, pharmacotherapy, and physical exercise are linked to the short-term reduction of depressed symptoms in older people with OA [35,47]. Besides, healthcare providers should adopt an integrated pain management approach, combining pharmacologic treatments (e.g., simple analgesics, NSAIDs, COX-2 inhibitors) with non-pharmacologic interventions (e.g., movement meditation, acupuncture, and psychological therapy) to reduce pain-related anxiety and depression in OA patients [48–50].

From policy standpoint, our results highlight the importance of integration of mental health screening into routine OA care at primary and specialty healthcare settings [34]. Governments and health insurance providers must enhance access to affordable mental health services by reducing financial barriers for uninsured and underinsured populations. This could include expanding publicly funded mental health programs and increasing coverage for psychological services in health insurance plans. This is especially important due to the high cost of mental health care, as people with mental illnesses have historically faced major barriers to seeking mental health care for the uninsured and even those who are insured [51]. These challenges are especially pronounced among low-income and unemployed populations, who, as demonstrated in our analysis, are disproportionately burdened by comorbid mental health conditions and reduced HRQoL.

The public health implications encourage lifestyle changes like physical activity. Physical activity equivalent to 150 minutes per week of moderate-intensity aerobic activity or 75 minutes per week of vigorous aerobic activity, or a combination of both can have a detrimental positive impact on HRQoL [42,52,53], decreased OA pain [53], improve physical function of OA patients [52,53]. Public health agencies should leverage exercise-based interventions as a cost-effective alternative to antidepressant treatment, given its comparable benefits in reducing depression and anxiety in OA patients [54,55].

Future research should aim to address several limitations identified in this study and further explore the complex interplay between osteoarthritis (OA), mental health, and health-related quality of life (HRQoL). Longitudinal cohort studies are needed to establish causal relationships between anxiety, depression, and changes in HRQoL over time. Additionally, future investigations should incorporate OA specific clinical variables such as pain severity, functional limitation, disease subtype, treatment regimens, and joint location which were not available in the current dataset but are known to substantially influence HRQoL outcomes. Moreover, research focusing on intervention strategies, including integrated care models, physical activity programs, and mental health support tailored to OA patients, is essential to evaluate their effectiveness in real-world settings. Finally, incorporating patient-reported outcome measures and qualitative insights could enrich understanding of patient priorities and lived experiences, informing the design of more patient-centered care approaches.

5. Conclusions

The relationships between anxiety, depression, and a low HRQoL in patients with OA was found in this study. This study also revealed the negative effect of low education and low income on HRQoL while highlighting the advantages of employment and regular exercise. It is crucial for future research to thoroughly evaluate patient-centered clinical approaches care and management policies. This understanding of risk factors that hinder patients with OA, which increase anxiety and depression risk and therefore compromise the HRQoL in individuals with OA, is worthy.

Abbreviations

HRQoL

health-related quality of life

MCS

mental health component score

PCS

physical health component score

Data Availability

The dataset used in this study is available from the MEPS database at this URL: https://meps.ahrq.gov/mepsweb/data_stats/download_data_files.jsp.

Funding Statement

This research was supported by the Ongoing Research Funding Program, (ORF-2025-1128), King Saud University, Riyadh, Saudi Arabia.

References

  • 1.Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthritis Cartilage. 2022;30(1):10–6. doi: 10.1016/j.joca.2021.05.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, Fukutaki KG. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022;30(2):184–95. doi: 10.1016/j.joca.2021.04.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Scheuing WJ, Reginato AM, Deeb M, Acer Kasman S. The burden of osteoarthritis: Is it a rising problem? Best Pract Res Clin Rheumatol. 2023;37(2):101836. doi: 10.1016/j.berh.2023.101836 [DOI] [PubMed] [Google Scholar]
  • 5.Rothrauff B, Tang Q, Wang J, He J. Osteoarthritis is positively associated with self-reported sleep trouble in older adults. Aging Clin Exp Res. 2022;34(11):2835–43. doi: 10.1007/s40520-022-02225-6 [DOI] [PubMed] [Google Scholar]
  • 6.Chang W-Y, Choi S, Yoo SJ, Lee J, Lim C. Factors associated with osteoarthritis and their influence on health-related quality of life in older adults with osteoarthritis: a study based on the 2020 Korea National Health and Nutrition Examination Survey. Int J Environ Res Public Health. 2023;20(12):6073. doi: 10.3390/ijerph20126073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zhao X, Shah D, Gandhi K, Wei W, Dwibedi N, Webster L, et al. Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States. Osteoarthritis Cartilage. 2019;27(11):1618–26. doi: 10.1016/j.joca.2019.07.002 [DOI] [PubMed] [Google Scholar]
  • 8.Savvari P, Skiadas I, Papadakis SA, Psychogios V, Argyropoulou OD, Pastroudis AP, et al. The impact of moderate to severe osteoarthritis on the physical performance and quality of life: a cross-sectional study in Greek patients (PONOS study). BMC Musculoskelet Disord. 2023;24(1):651. doi: 10.1186/s12891-023-06770-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jin X, Liang W, Zhang L, Cao S, Yang L, Xie F. Economic and humanistic burden of osteoarthritis: an updated systematic review of large sample studies. Pharmacoeconomics. 2023;41(11):1453–67. doi: 10.1007/s40273-023-01296-1 [DOI] [PubMed] [Google Scholar]
  • 10.Yan H, Guo J, Zhou W, Dong C, Liu J. Health-related quality of life in osteoarthritis patients: a systematic review and meta-analysis. Psychol Health Med. 2022;27(8):1859–74. doi: 10.1080/13548506.2021.1971725 [DOI] [PubMed] [Google Scholar]
  • 11.Wang S-T, Ni G-X. Depression in osteoarthritis: current understanding. Neuropsychiatr Dis Treat. 2022;18:375–89. doi: 10.2147/NDT.S346183 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sambamoorthi U, Shah D, Zhao X. Healthcare burden of depression in adults with arthritis. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):53–65. doi: 10.1080/14737167.2017.1281744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fonseca-Rodrigues D, Rodrigues A, Martins T, Pinto J, Amorim D, Almeida A, et al. Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford). 2021;61(1):53–75. doi: 10.1093/rheumatology/keab512 [DOI] [PubMed] [Google Scholar]
  • 14.Rosemann T, Gensichen J, Sauer N, Laux G, Szecsenyi J. The impact of concomitant depression on quality of life and health service utilisation in patients with osteoarthritis. Rheumatol Int. 2007;27(9):859–63. doi: 10.1007/s00296-007-0309-6 [DOI] [PubMed] [Google Scholar]
  • 15.Tsuji T, Nakata K, Vietri J, Jaffe DH. The added burden of depression in patients with osteoarthritis in Japan. Clinicoecon Outcomes Res. 2019;11:411–21. doi: 10.2147/CEOR.S189610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Agarwal P, Sambamoorthi U. Healthcare expenditures associated with depression among individuals with osteoarthritis: post-regression linear decomposition approach. J Gen Intern Med. 2015;30(12):1803–11. doi: 10.1007/s11606-015-3393-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lee Y, Lee S-H, Lim SM, Baek SH, Ha I-H. Mental health and quality of life of patients with osteoarthritis pain: the sixth Korea National Health and Nutrition Examination Survey (2013–2015 ). PLOS ONE. 2020;15(11):e0242077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kim D-J. A Study on the physical activities, mental health, and health-related quality of life of osteoarthritis patients. Osong Public Health Res Perspect. 2019;10(6):368–75. doi: 10.24171/j.phrp.2019.10.6.07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34(7):645–9. doi: 10.1007/s40273-016-0389-9 [DOI] [PubMed] [Google Scholar]
  • 20.Pinto Barbosa S, Marques L, Sugawara A, Toledo F, Imamura M, Battistella L, et al. Predictors of the Health-Related Quality of Life (HRQOL) in SF-36 in knee osteoarthritis patients: a multimodal model with moderators and mediators. Cureus. 2022;14(7):e27339. doi: 10.7759/cureus.27339 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tavares DRB, Moça Trevisani VF, Frazao Okazaki JE, Valéria de Andrade Santana M, Pereira Nunes Pinto AC, Tutiya KK, et al. Risk factors of pain, physical function, and health-related quality of life in elderly people with knee osteoarthritis: a cross-sectional study. Heliyon. 2020;6(12):e05723. doi: 10.1016/j.heliyon.2020.e05723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey HC-231: 2021 Medical Conditions File. 2024. Available from: https://meps.ahrq.gov/data_stats/download_data/pufs/h231/h231doc.pdf [Google Scholar]
  • 23.Maslak JP, Jenkins TJ, Weiner JA, Kannan AS, Patoli DM, McCarthy MH. Burden of Sciatica on US medicare recipients. JAAOS - J Am Acad Orthop Surg. 2020;28(10):e433–9. [DOI] [PubMed] [Google Scholar]
  • 24.Selim AJ, Rothendler JA, Qian SX, Bailey HM, Kazis LE. The history and applications of the veterans RAND 12-item health survey (VR-12). J Ambul Care Manage. 2022;45(3):161–70. doi: 10.1097/JAC.0000000000000420 [DOI] [PubMed] [Google Scholar]
  • 25.Kazis LE, Rogers WH, Rothendler J, Qian S, Selim A, Edelen MO. Outcome Performance Measure Development for Persons with Multiple Chronic Conditions. Santa Monica, CA: RAND Corporation; 2017. [Google Scholar]
  • 26.Cheak-Zamora NC, Wyrwich KW, McBride TD. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res. 2009;18(6):727–35. doi: 10.1007/s11136-009-9483-1 [DOI] [PubMed] [Google Scholar]
  • 27.Heyworth ITM, Hazell ML, Linehan MF, Frank TL. How do common chronic conditions affect health-related quality of life? Br J Gen Pract. 2009;59(568):e353–8. doi: 10.3399/bjgp09X453990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Keles H, Ekici A, Ekici M, Bulcun E, Altinkaya V. Effect of chronic diseases and associated psychological distress on health-related quality of life. Intern Med J. 2007;37(1):6–11. doi: 10.1111/j.1445-5994.2006.01215.x [DOI] [PubMed] [Google Scholar]
  • 29.Kivits J, Erpelding M-L, Guillemin F. Social determinants of health-related quality of life. Rev Epidemiol Sante Publique. 2013;61 Suppl 3:S189-94. doi: 10.1016/j.respe.2013.06.001 [DOI] [PubMed] [Google Scholar]
  • 30.Saffari M, Meybodi MKE, Ghanizadeh G, Koenig HG. Determinants of health status among patients with knee or hip osteoarthritis: the role of demographic, clinical and health related quality of life variables. J Musculoskelet Res. 2014;17(01):1450004. doi: 10.1142/s0218957714500043 [DOI] [Google Scholar]
  • 31.Yuniarwati W, Subijanto AA, Prasetyo H. Determinants of quality of life among patient with knee osteoarthritis. J Epidemiol Public Health. 2019;4(4):320–7. doi: 10.26911/jepublichealth.2019.04.04.07 [DOI] [Google Scholar]
  • 32.Luong M-LN, Cleveland RJ, Nyrop KA, Callahan LF. Social determinants and osteoarthritis outcomes. Aging Health. 2012;8(4):413–37. doi: 10.2217/ahe.12.43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bharmal M, Thomas J 3rd. Health insurance coverage and health-related quality of life: analysis of 2000 Medical Expenditure Panel Survey data. J Health Care Poor Underserved. 2005;16(4):643–54. [DOI] [PubMed] [Google Scholar]
  • 34.Mallen CD, Nicholl BI, Lewis M, Bartlam B, Green D, Jowett S, et al. The effects of implementing a point-of-care electronic template to prompt routine anxiety and depression screening in patients consulting for osteoarthritis (the Primary Care Osteoarthritis Trial): a cluster randomised trial in primary care. PLoS Med. 2017;14(4):e1002273. doi: 10.1371/journal.pmed.1002273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sharma A, Kudesia P, Shi Q, Gandhi R. Anxiety and depression in patients with osteoarthritis: impact and management challenges. Open Access Rheumatol: Res Rev. 2016;8:103–13. doi: 10.2147/OARRR.S93516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management. 2022. Available from: https://www.nice.org.uk/guidance/ng226/resources/osteoarthritis-in-over-16s-diagnosis-and-management-pdf-66143839026373 [PubMed] [Google Scholar]
  • 37.Gleicher Y, Croxford R, Hochman J, Hawker G. A prospective study of mental health care for comorbid depressed mood in older adults with painful osteoarthritis. BMC Psychiatry. 2011;11:147. doi: 10.1186/1471-244X-11-147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Costa D, Lopes DG, Cruz EB, Henriques AR, Branco J, Canhão H, et al. Trajectories of physical function and quality of life in people with osteoarthritis: results from a 10-year population-based cohort. BMC Public Health. 2023;23(1):1407. doi: 10.1186/s12889-023-16167-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Park Y, Park K. Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea. Front Psychol. 2023;14:1117369. doi: 10.3389/fpsyg.2023.1117369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Maynié-François C, Burtey S. Comparing health-related quality of life in chronic diseases: the importance of analyzing references. Nat Rev Dis Primers. 2019;5(1):28. doi: 10.1038/s41572-019-0082-3 [DOI] [PubMed] [Google Scholar]
  • 41.Megari K. Quality of life in chronic disease patients. Health Psychol Res. 2013;1(3):e27. doi: 10.4081/hpr.2013.e27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Anokye NK, Trueman P, Green C, Pavey TG, Taylor RS. Physical activity and health related quality of life. BMC Public Health. 2012;12:624. doi: 10.1186/1471-2458-12-624 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chang J, Yuan Y, Fu M, Wang D. Health-related quality of life among patients with knee osteoarthritis in Guangzhou, China: a multicenter cross-sectional study. Health Qual Life Outcomes. 2023;21(1):50. doi: 10.1186/s12955-023-02133-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Montero A, Mulero J-F, Tornero C, Guitart J, Serrano M. Pain, disability and health-related quality of life in osteoarthritis-joint matters: an observational, multi-specialty trans-national follow-up study. Clin Rheumatol. 2016;35(9):2293–305. doi: 10.1007/s10067-016-3248-3 [DOI] [PubMed] [Google Scholar]
  • 45.Frankish H, Boyce N, Horton R. Mental health for all: a global goal. Lancet. 2018;392(10157):1493–4. doi: 10.1016/S0140-6736(18)32271-2 [DOI] [PubMed] [Google Scholar]
  • 46.National Institute for Health and Care Excellence. Depression in adults: treatment and management. 2022. Available from: https://www.nice.org.uk/guidance/ng222 [PubMed] [Google Scholar]
  • 47.Yohannes AM, Caton S. Management of depression in older people with osteoarthritis: a systematic review. Aging Ment Health. 2010;14(6):637–51. doi: 10.1080/13607860903483094 [DOI] [PubMed] [Google Scholar]
  • 48.Burley CV, Casey A-N, Jones MD, Wright KE, Parmenter BJ. Nonpharmacological approaches for pain and symptoms of depression in people with osteoarthritis: systematic review and meta-analyses. Sci Rep. 2023;13(1):15449. doi: 10.1038/s41598-023-41709-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Manyanga T, Froese M, Zarychanski R, Abou-Setta A, Friesen C, Tennenhouse M, et al. Pain management with acupuncture in osteoarthritis: a systematic review and meta-analysis. BMC Complement Altern Med. 2014;14:312. doi: 10.1186/1472-6882-14-312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Walker-Bone K, Javaid K, Arden N, Cooper C. Regular review: medical management of osteoarthritis. BMJ. 2000;321(7266):936–40. doi: 10.1136/bmj.321.7266.936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Rowan K, McAlpine DD, Blewett LA. Access and cost barriers to mental health care, by insurance status, 1999-2010. Health Aff. 2013;32(10):1723–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Lopes DG, Costa D, Cruz EB, Mendonça N, Henriques AR, Branco J, et al. Association of physical activity with physical function and quality of life in people with hip and knee osteoarthritis: longitudinal analysis of a population-based cohort. Arthritis Res Ther. 2023;25(1):14. doi: 10.1186/s13075-023-02996-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kraus VB, Sprow K, Powell KE, Buchner D, Bloodgood B, Piercy K, et al. Effects of physical activity in knee and hip osteoarthritis: a systematic umbrella review. Med Sci Sports Exerc. 2019;51(6):1324–39. doi: 10.1249/MSS.0000000000001944 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Dinas PC, Koutedakis Y, Flouris AD. Effects of exercise and physical activity on depression. Ir J Med Sci. 2011;180(2):319–25. doi: 10.1007/s11845-010-0633-9 [DOI] [PubMed] [Google Scholar]
  • 55.Kandola A, Ashdown-Franks G, Hendrikse J, Sabiston CM, Stubbs B. Physical activity and depression: towards understanding the antidepressant mechanisms of physical activity. Neurosci Biobehav Rev. 2019;107:525–39. doi: 10.1016/j.neubiorev.2019.09.040 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Zulkarnain Jaafar

Apr 16 2025

PONE-D-24-50708Mental Health and Health-Related Quality of Life among Adults with Osteoarthritis: A National Population-Based StudyPLOS ONE

Dear Dr. Alwhaibi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

=============================ACADEMIC EDITOR: Dear Author, please attend to all of the comments provided by the reviewer/s . ==============================

Please submit your revised manuscript by Apr 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Zulkarnain Jaafar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf .

2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.

At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories .

3. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex .

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: SYNOPSIS:

Mental Health and Health-Related Quality of 1 Life among Adults with Osteoarthritis: A National Population-Based Study

The study is a good addition to knowledge; especially as it utilized a robust data which makes generalizability easier. However, the manuscript will need some fine tuning to improve its quality. If some of the of the recommendations are taken, it might improve the quality of the work.

Details of my observations are attached as comments on the manuscripts. Below are my general observations:

Data analysis:

what determine the inclusion of candidate variables into the multivariable linear regression model?... or all variables were loaded into the omnibus model? ......kindly state this?

Results:

I hope it is the Likelihood Ratio p-value that was reported for the p-values; and indicated as such; as this table is filled with K by K or 2 by K Chi-squares.

All significant results should be reported and not just one from a group of significant variables.

Be specific about the domain you are reporting.

Ensure that all reported regression result ends with a comparison with the reference group.

Discussion:

Discussing an insignificant result while leaving out the significant result might not be okay. E.g gender.

Recommendations:

recommendations should be addressed to specific entities and for specific entities.

References:

Some need re-editing; some revising and incomplete references completed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  PHILIP ADEWALE ADEOYE (Jos University Teaching Hospital, Nigeria)

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: [reviewed]PONE-D-24-50708.pdf

pone.0325780.s001.pdf (859.7KB, pdf)
PLoS One. 2025 Jun 18;20(6):e0325780. doi: 10.1371/journal.pone.0325780.r003

Author response to Decision Letter 1


7 Mar 2025

Response to Reviewer Comments

We appreciate the reviewer’s thoughtful comments and suggestions, which have helped improve the clarity and quality of our manuscript. Below is our detailed response to each comment:

Data Analysis:

Comment 1: Inclusion of Candidate Variables in Multivariable Linear Regression Model

Response: Thank you for this comment; we have now clarified the selection process of variables in the Methods section. Variables were included based on their theoretical relevance, clinical importance, and prior literature supporting their association with health-related quality of life (HRQoL) in osteoarthritis (OA) patients. Additionally, a bivariate analysis was performed, and only variables with a p-value <0.05 were considered for the multivariable regression model.

Results:

Comment 2: Likelihood Ratio p-value Indication

Response: We have ensured that the reported p-values are based on the likelihood ratio test where appropriate and have explicitly indicated this in the text and tables.

Comment 3: Reporting All Significant Results

Response: We have revised the results section to ensure that all significant findings are reported.

Comment 4: Specificity about Domains Being Reported

Response: Thanks for pointing out, now we have specify whether the reported HRQoL results pertain to the Physical Component Summary (PCS) or the Mental Component Summary (MCS) to enhance clarity.

Comment 5: Comparison with the Reference Group

Response: Thanks for this comment; we have ensured that all the reported regression results include a clear comparison with the reference group.

Discussion:

Comment 6: Addressing Significant vs. Insignificant Results

Response: The discussion has been revised to emphasize significant results while removing discussion on insignificant findings (i.e., gender was previously discussed despite being statistically insignificant; this has now been removed).

Comment 7: Comprehensive Reporting of Key Variables

Response: As per the reviewer recommendations, we have expanded the discussion to cover all significant factors, including perceived health, employment, region, and income, as they were significantly associated with HRQoL. We have also clarified the role of education by providing possible explanations for the observed findings and comparing them with previous studies.

Recommendations:

Comment 8: Specificity in Recommendations

Response: Thanks for the suggestion. Recommendations have been revised to clearly address specific entities such as healthcare providers, policymakers, and public health organizations.

Comment 9: Re-editing and Completing References

Response: The reference section has been thoroughly revised to ensure completeness, correct formatting, and accuracy.

Attachment

Submitted filename: OA_HRQoL_Response to reviewer_05-03-2025.docx

pone.0325780.s002.docx (20.1KB, docx)

Decision Letter 1

Zulkarnain Jaafar

May 23 2025

PONE-D-24-50708R1Mental Health and Health-Related Quality of Life among Adults with Osteoarthritis: A National Population-Based StudyPLOS ONE

Dear Dr. Alwhaibi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Dear Author, please attend to all comments provided by the reviewers.==============================

Please submit your revised manuscript by May 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Zulkarnain Jaafar

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have attended to ALL the pervious comments/observations. However, there remain some observations made on the uploaded manuscript as comments. In summary

1. The need to rephrase the title of a table to make it clearer

2. some incorrect narration

3. likely incorrectly stated public health implications.

Once, these concerns are addressed, the work can be accepted for publication.

Thank you.

Reviewer #2: The present study is highly relevant and timely, grounded in a substantial body of literature and organized in a coherent manner. However, there are aspects that can be enhanced to make the work more robust and well-founded. The main areas for potential improvement will be discussed below.

1. Introduction and Theoretical Framework

Although the introduction is well-structured, it could be strengthened by including a more comprehensive review of the existing literature. Presenting previous studies related to the topic, along with their main findings and identified gaps, would contribute to a more solid theoretical foundation.

Additionally, it is essential that fundamental concepts be discussed in greater detail, considering different theoretical and methodological perspectives. A critical analysis of the literature would allow for the identification of alternative approaches and their justification based on clear criteria, such as methodological adequacy, validity of results, and relevance to the investigated context.

2. Justification of the Study

Although the study presents clear objectives, the justification could be enhanced by providing a more detailed explanation of the reasons underlying the choice of the variables investigated. It is necessary to discuss how these variables relate to the research problem and how they contribute to advancing knowledge in the field.

The selection of measurement scales should be justified based on their validity, reliability, and suitability to the study context. Moreover, it is important to address potential biases that may arise from the use of these scales and how they were controlled or minimized in the research.

3. Methodology and Statistical Approach

From a methodological standpoint, the study presents an appropriate design; however, the description of the procedures used could be expanded to provide greater clarity and transparency.

4. Results

The results are clearly presented, with appropriate use of tables, diagrams, and graphs that facilitate the understanding of the findings. However, it is recommended to deepen the discussion of the results by considering different possible interpretations and relating them to previous studies.

In summary, the research has the potential to contribute significantly to the field of study. However, it is essential that the conclusions be based on a rigorous and critical analysis of the findings. It is recommended to discuss not only the direct impacts of the study but also its implications for public policy, clinical practice, and future research. Comparing the findings with other realities, particularly international ones, can provide valuable insights into the relevance of the results.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  ADEOYE, Philip Adewale (Jos-Nigeria)

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-24-50708_R2.pdf

pone.0325780.s003.pdf (1.5MB, pdf)
PLoS One. 2025 Jun 18;20(6):e0325780. doi: 10.1371/journal.pone.0325780.r005

Author response to Decision Letter 2


30 Apr 2025

We thank the reviewers for their valuable feedback, which has greatly contributed to improving our manuscript. Below, we provide a detailed response to each comment and describe the corresponding revisions made.

Reviewer 1

Comment 1: The need to rephrase the title of a table to make it clearer

Response: Thank you for this suggestion; we have revised the title of the relevant table to improve clarity. Specifically, the title was changed to: Table 1. Socioeconomic and health-related characteristic of study participants across osteoarthritis groups.

Comment 2: some incorrect narration

Response: We carefully reviewed the results and corrected instances of inaccurate or unclear narration (Page 11, Lines 228-230).

Comment 3: likely incorrectly stated public health implications.

Response: We have revised the physical activity recommendations align with current American Heart Association Recommendations for Physical Activity in Adults (Page 19, Lines 371-373).

Reviewer 2

Comment 1: Introduction and Theoretical Framework

Although the introduction is well-structured, it could be strengthened by including a more comprehensive review of the existing literature. Presenting previous studies related to the topic, along with their main findings and identified gaps, would contribute to a more solid theoretical foundation.

Additionally, it is essential that fundamental concepts be discussed in greater detail, considering different theoretical and methodological perspectives. A critical analysis of the literature would allow for the identification of alternative approaches and their justification based on clear criteria, such as methodological adequacy, validity of results, and relevance to the investigated context.

Response: Thank you for your constructive feedback. In response, we have expanded the introduction to include a more comprehensive and critical review of the existing literature. Specifically, we now discuss key methodological limitations in previous studies, such as reliance on self-reported data (Chang et al.), selection bias from online surveys (Tsuji et al.), outdated or single-year data (Kim et al.), small sample sizes (Barbosa et al.), and gender imbalance (Tavares et al.). These additions clarify existing knowledge gaps and support the rationale for our use of a nationally representative U.S. dataset (MEPS) with validated diagnostic codes and HRQoL measures. We believe these enhancements have strengthened the theoretical foundation and contextual relevance of our study (Page 4, Lines 84-103).

Comment 2: Justification of the Study

Although the study presents clear objectives, the justification could be enhanced by providing a more detailed explanation of the reasons underlying the choice of the variables investigated. It is necessary to discuss how these variables relate to the research problem and how they contribute to advancing knowledge in the field.

The selection of measurement scales should be justified based on their validity, reliability, and suitability to the study context. Moreover, it is important to address potential biases that may arise from the use of these scales and how they were controlled or minimized in the research.

Response: We thank the reviewer for this valuable comment. In the revised manuscript, we have expanded the justification for variable selection and clarified how they relate to the research objectives (Page 6-7, Lines 143-153).

Comment 3: Methodology and Statistical Approach

From a methodological standpoint, the study presents an appropriate design; however, the description of the procedures used could be expanded to provide greater clarity and transparency.

Response: We appreciate the reviewer’s valuable feedback. In response, we have revised the Methods section to expand and clarify the study procedures (Page 5, Lines 109-121).

Comment 4: Results

The results are clearly presented, with appropriate use of tables, diagrams, and graphs that facilitate the understanding of the findings. However, it is recommended to deepen the discussion of the results by considering different possible interpretations and relating them to previous studies.

In summary, the research has the potential to contribute significantly to the field of study. However, it is essential that the conclusions be based on a rigorous and critical analysis of the findings. It is recommended to discuss not only the direct impacts of the study but also its implications for public policy, clinical practice, and future research. Comparing the findings with other realities, particularly international ones, can provide valuable insights into the relevance of the results.

Response: Thank you for the constructive feedback. We have expanded the Discussion section to include interpretations, comparisons with international studies (Pages 13-14, Lines 240-253), and broader implications for policy, clinical practice, public and future research (Pges 18-20, Lines 346-389). These enhancements ensure a more rigorous and contextually grounded interpretation of the findings.

Attachment

Submitted filename: OA_HRQoL_Response_to_reviewer_05-03-2025_auresp_2.docx

pone.0325780.s004.docx (20.1KB, docx)

Decision Letter 2

Zulkarnain Jaafar

Mental Health and Health-Related Quality of Life among Adults with Osteoarthritis: A National Population-Based Study

PONE-D-24-50708R2

Dear Dr. Alwhaibi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Zulkarnain Jaafar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The author had adequately attended to my observations and comments in the two rounds of earlier reviews. I recommend this article for acceptance for publication. Thank you for the opportunity to review this work.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  ADEOYE, Philip Adewale (Jos University Teaching Hospital, Nigeria)

**********

Acceptance letter

Zulkarnain Jaafar

PONE-D-24-50708R2

PLOS ONE

Dear Dr. Alwhaibi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Zulkarnain Jaafar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: [reviewed]PONE-D-24-50708.pdf

    pone.0325780.s001.pdf (859.7KB, pdf)
    Attachment

    Submitted filename: OA_HRQoL_Response to reviewer_05-03-2025.docx

    pone.0325780.s002.docx (20.1KB, docx)
    Attachment

    Submitted filename: PONE-D-24-50708_R2.pdf

    pone.0325780.s003.pdf (1.5MB, pdf)
    Attachment

    Submitted filename: OA_HRQoL_Response_to_reviewer_05-03-2025_auresp_2.docx

    pone.0325780.s004.docx (20.1KB, docx)

    Data Availability Statement

    The dataset used in this study is available from the MEPS database at this URL: https://meps.ahrq.gov/mepsweb/data_stats/download_data_files.jsp.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES